Still's Disease Abstracts at EULAR 2023 Save
Dr. Jack Cush reviews the following research presented at EULAR 2023 in Milan
- AB1484 (2023) G. Fontana, et al. ADULT-ONSET STILL’S DISEASE AND SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: PREDICTORS OF DRUG-FREE REMISSION IN A MONOCENTRIC COHORT
- OP0257 (2023) N. Farina, et al. CANAKINUMAB IN THE TREATMENT OF ADULT-ONSET STILL’S DISEASE: LONG TERM DATA FROM A MONOCENTRIC COHORT
- AB1503 (2023) I. DI Cola1, F. Ursini2,3, R. Giacomelli4, P. Cipriani1, P. Ruscitti. THE IMPACT OF OBESITY ON CLINICAL COURSE AND BIOLOGIC DMARD FAILURE IN PATIENTS WITH ADULT ONSET STILL’S DISEASE
- OP0034 (2023) D. Foell, et al. A NOVEL SERUM CALPROTECTIN (MRP8/14) PARTICLE ENHANCED IMMUNO-TURBIDIMETRIC ASSAY (SCAL TURBO) HELPS TO DIFFERENTIATE SJIA FROM OTHER DISEASES IN ROUTINE CLINICAL LABORATORY SETTINGS
- AB1307 (2023) S. Bindoli, et al. ANALYSIS OF ANTI-SARS-CoV-2 S-RBD IGG ANTIBODY LEVELS IN A COHORT OF PATIENTS RECEIVING IL-1 INHIBITORS
- POS0277 (2023) C. Bracaglia, et al. SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS ASSOCIATED LUNG DISEASE IN EUROPE
Disclosures
The author has received compensation as an advisor or consultant on this subject
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.